The Relationship of CXCL12 with Sperm Agglutination and Anti-Sperm Antibody Among Infertile Men
Abstract
Background: It is known that structural elements like the ‘blood-testis barrier’ (BTB) and local & systemic tolerance mechanisms help to maintain testicular homeostasis, which shields germ cells and mature sperms from immune attack. Any damage to this barrier could result in immune attack and may cause infertility.
Methods: The most important goal of this study was to find the vital connection between male infertility and immunological factors (CXCL12 and anti-sperm antibody). During the months of October 2021 and July 2022, a total of 144 samples were taken from patients who sought to have infertility tested. Semen and blood samples were taken from the subjects to assess seminal plasma CXCL12 levels and the prevalence of anti-sperm antibody (ASA) in their serum. Alternatively, research on sperm function parameters, sperm agglutination risk, and its relationship to ASA and CXCL12.
Result: statistically there was no ‘significant’ difference in CXCL12 levels across study groups in this investigation. The prevalence of sperm agglutination was 23.61% across all patients under study, the majority of whom had asthenozoospermia. In contrast, 60% of the samples from ASA-positive patients were agglutinated. The results revealed a relatively weak positive link that may call for additional research even if there was no significant statistical correlation in the relationship between CXCL12 and sperm functions and ASA.
Conclusion: The findings of this study suggest that ASA affects seminal fluid parameters, which in turn affects male fertility, and that a weak, non-significant association between CXCL12 and sperm function could impair sperm function by reducing sperm motility. Sperm agglutination could be a sign of immunological infertility. ASA can impact male fertility in a number of ways. Others had to do with sperm agglutination.
Keywords: CXCL12; Anti-sperm antibody; ASA; Sperm agglutination; Sperm function
Full Text:
PDFReferences
Harrison JE, Weber S, Jakob R, Chute CG. ICD-11: an international classification of diseases for the twenty-first century. BMC medical informatics and decision making, (2021); 21, 1-10.
Agarwal A, Baskaran S, Parekh N, Cho CL, Henkel R, et al. Male infertility. The Lancet, (2021); 397(10271): 319-333.
Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. The Journal of Immunology, (2002); 169(1): 424-433.
Mao TL, Fan KF, Liu C L. Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer. Gene therapy, (2017); 24(10): 621-629.
Huynh C, Dingemanse J, Zu Schwabedissen HEM, Sidharta PN. Relevance of the CXCR4/CXCR7-CXCL12 axis and its effect in pathophysiological conditions. Pharmacological Research, (2020); 161: 105092.
AS V, Dhama K, Chakraborty S, Abdul Samad, H, K Latheef S, et al. Role of antisperm antibodies in infertility, pregnancy, and potential for contraceptive and antifertility vaccine designs: Research progress and pioneering vision. Vaccines, (2019); 7(3): 116.
Lu SM, Li X, Wang S L, Yang X L, Xu YZ, et al. Success rates of in vitro fertilization versus intracytoplasmic sperm injection in men with serum anti-sperm antibodies: a consecutive cohort study. Asian Journal of Andrology, (2019); 21(5): 473.
Parida, R. Human MOSPD2: A bacterial Lmb mimicked auto-antigen is involved in immune infertility. Journal of translational autoimmunity, (2019); 1, 100002.
Westerman, R. Biomarkers for demographic research: Sperm counts and other male infertility biomarkers. Biodemography and Social Biology, (2020); 65(1): 73-87.
Piroozmand A, Nasab SDM, Erami M, Hashemi SMA, Khodabakhsh E, et al. Distribution of human papillomavirus and antisperm antibody in semen and its association with semen parameters among infertile men. Journal of Reproduction & Infertility, (2020); 21(3): 183.
Matzinger P. The danger model: a renewed sense of self. science, (2002); 296(5566): 301-305.
Archana SS, Selvaraju S, Binsila BK, Arangasamy A, Krawetz SA. Immune regulatory molecules as modifiers of semen and fertility: A review. Molecular Reproduction and Development, (2019); 86(11): 1485-1504.
Azizi G, Namaki S, Mirshafiey A, Hamid KM. HLA antigens and anti-sperm antibody production in Iranian vasectomized men. Journal of biomedical research, (2015); 29(1): 87.
Xu F, Ye L, Hu Y, Cai C, Wang Z, et al. A novel protein biochip screening serum anti-sperm antibody expression and natural pregnancy rate in a follow-up study in Chinese infertility. Bioscience Reports, (2020); 40(2): BSR20191769.
Lotti F, Baldi E, Corona G, Lombardo F, Maseroli E, et al. Epididymal more than testicular abnormalities are associated with the occurrence of antisperm antibodies as evaluated by the MAR test. Human Reproduction, (2018); 33(8): 1417-1429.
Barbonetti A, Castellini C, D’Andrea S, Cordeschi G, Santucci R, et al. Prevalence of anti-sperm antibodies and relationship of degree of sperm auto-immunization to semen parameters and post-coital test outcome: a retrospective analysis of over 10 000 men. Human Reproduction, (2019); 34(5): 834-841.
Al-Daghistani HI. Staphylococcusaureus protein A as a means of assessing sperm penetrability in cervical mucus in vitro. Clinical and Experimental Reproductive Medicine, (2020); 47(3): 186.
Björndahl L, Brown JK. The sixth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen: ensuring quality and standardization in basic examination of human ejaculates. Fertility and sterility, (2022); 117(2), 246-251.
Alhajj M, Zubair M, Farhana A. Enzyme linked immunosorbent assay [Internet]. U.S. National Library of Medicine; 2023 [cited 2023 Apl 24]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK555922/
Sugiyama H, Chandler DE. Sperm guidance to the egg finds calcium at the helm. Protoplasma, (2014); 251: 461-475.
Wang C, Huang J, Ding L, Huang R, Dai L, et al. Effects of CXCL12/CXCR4/CXCR7 axis on human sperm motility and chemotaxis. bioRxiv, (2019); 831065.
Hatef B, Taromchi A, Nejatbakhsh R, Farrokhi A, Shokri S. Supplementation of freezing media with stromal cell-derived factor-1α preserves human sperm from cryodamage. Cryobiology, (2017); 79: 37-42.
Hakimi H, Zainodini N, Khorramdelazad H, Arababadi MK, Hassanshahi G. Seminal levels of pro-inflammatory (CXCL1, CXCL9, CXCL10) and homeostatic (CXCL12) chemokines in men with asymptomatic Chlamydia trachomatis infection. Jundishapur journal of microbiology, (2014); 7(12): e11152
Politch JA, Tucker L, Bowman FP, Anderson DJ. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Human Reproduction, (2007); 22(11): 2928-2935.
Calagna G, Catinella V, Polito S, Schiattarella A, De Franciscis P, et al. Vitamin D and Male Reproduction: Updated Evidence Based on Literature Review. Nutrients, (2022); 14(16): 3278.
Otasevic V, Kalezic A, Macanovic B, Jankovic A, Stancic A, et al. Evaluation of the antioxidative enzymes in the seminal plasma of infertile men: Contribution to classic semen quality analysis. Systems biology in reproductive medicine, (2019); 65(5): 343-349.
Shibahara H, Chen Y, Honda H, Wakimoto Y, Fukui A, et al. Sex difference in anti‐sperm antibodies. Reproductive Medicine and Biology, (2022); 21(1): e12477.
Silva AF, Ramalho-Santos J, Amaral S. The impact of antisperm antibodies on human male reproductive function: An update. Reproduction, (2021), 162(4): R55-R71.
Cui D, Han G, Shang Y, Liu C, Xia L, et al. Antisperm antibodies in infertile men and their effect on semen parameters: a systematic review and meta-analysis. Clinica Chimica Acta, (2015); 444: 29-36.
Lee R, Goldstein M, Ullery BW, Ehrlich J, Soares M, et al. Value of serum antisperm antibodies in diagnosing obstructive azoospermia. The Journal of urology, (2009); 181(1): 264-269.
DOI: http://dx.doi.org/10.62940/als.v11i4.2552
Refbacks
- There are currently no refbacks.